Photocure
Less than 1K followers
PHO
Oslo Børs
Biotechnology & Pharmaceuticals
Health Care
Overview
Investor consensus
Photocure is a medical technology company. The company specializes in photodynamic technology solutions. The solutions are used to treat diseases that cause bladder cancer and HPV. The main markets are dermatology and oncology, where the products are used by hospitals and research institutes worldwide. The company was founded in 1993 and is headquartered in Oslo, Norway.
Read moreMarket cap
-
Turnover
-
Revenue
532.58M
EBIT %
-0.14 %
P/E
-
Dividend yield-%
-
Financial calendar
4.5
2026
General meeting '26
7.5
2026
Interim report Q1'26
29.7
2026
Interim report Q2'26
All
Press releases
ShowingAll content types
Photocure: Trials in Progress presented at the European Association of Urology (EAU) 2026 congress aim to enable a more personalized bladder cancer care pathway
Asieris: CEVIRA Approved in China as First-in-Class Non-Invasive Therapy for Cervical Precancerous Lesions
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools